Pharma chief defends 400% drug price rise

Nostrum Laboratories’ Nirmal Mulye says he is right to charge as much as possible and slams FDA

Source: FT.com - Drugs and Healthcare - September 11, 2018 Category: Pharmaceuticals Source Type: news